A lot of these companies fee emboldened by the current US grift attitude and see a way to make even more profit. One didn’t even wait a couple of months before adding a 170% grift to their weight loss drug on widespread NHS adoption and the news coverage that came from it.
You’re probably right but I think the industry has always lobbied like this. I *think* the price hike you’re referring to was for private supply only - no change to NHS pricing.
NHS pricing has gone up too cpe.org.uk/our-news/mou...
Appreciate the correction Robin, cheers.